154 related articles for article (PubMed ID: 12592121)
1. F-18 FDG positron emission tomography and benign fractures.
Shon IH; Fogelman I
Clin Nucl Med; 2003 Mar; 28(3):171-5. PubMed ID: 12592121
[TBL] [Abstract][Full Text] [Related]
2. Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.
Shin DS; Shon OJ; Byun SJ; Choi JH; Chun KA; Cho IH
Skeletal Radiol; 2008 May; 37(5):415-21. PubMed ID: 18309481
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.
Nakamoto Y; Osman M; Wahl RL
Clin Nucl Med; 2003 Apr; 28(4):302-7. PubMed ID: 12642709
[TBL] [Abstract][Full Text] [Related]
4. Utility of FDG-PET in differential diagnosis of benign and malignant fractures in acute to subacute phase.
Kato K; Aoki J; Endo K
Ann Nucl Med; 2003 Feb; 17(1):41-6. PubMed ID: 12691129
[TBL] [Abstract][Full Text] [Related]
5. Sacral fractures: a potential pitfall of FDG positron emission tomography.
Fayad LM; Cohade C; Wahl RL; Fishman EK
AJR Am J Roentgenol; 2003 Nov; 181(5):1239-43. PubMed ID: 14573412
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET findings of vertebral compression fractures in osteoporosis: preliminary results.
Schmitz A; Risse JH; Textor J; Zander D; Biersack HJ; Schmitt O; Palmedo H
Osteoporos Int; 2002 Sep; 13(9):755-61. PubMed ID: 12195540
[TBL] [Abstract][Full Text] [Related]
7. Rapid normalization of osseous FDG uptake following traumatic or surgical fractures.
Zhuang H; Sam JW; Chacko TK; Duarte PS; Hickeson M; Feng Q; Nakhoda KZ; Guan L; Reich P; Altimari SM; Alavi A
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1096-103. PubMed ID: 12761597
[TBL] [Abstract][Full Text] [Related]
8. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET uptake in occult acute pelvic fracture.
Ravenel JG; Gordon LL; Pope TL; Reed CE
Skeletal Radiol; 2004 Feb; 33(2):99-101. PubMed ID: 14605771
[TBL] [Abstract][Full Text] [Related]
10. Comparison of MR imaging and FDG-PET/CT in the differential diagnosis of benign and malignant vertebral compression fractures.
Cho WI; Chang UK
J Neurosurg Spine; 2011 Feb; 14(2):177-83. PubMed ID: 21214309
[TBL] [Abstract][Full Text] [Related]
11. 11C-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET.
Zhang H; Tian M; Oriuchi N; Higuchi T; Watanabe H; Aoki J; Tanada S; Endo K
Nucl Med Commun; 2003 Mar; 24(3):273-9. PubMed ID: 12612468
[TBL] [Abstract][Full Text] [Related]
12. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants.
Shreve PD; Anzai Y; Wahl RL
Radiographics; 1999; 19(1):61-77; quiz 150-1. PubMed ID: 9925392
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET in a case of multiple bone metastases of gastric cancer.
Nakai T; Okuyama C; Kubota T; Ushijima Y; Nishimura T
Ann Nucl Med; 2005 Feb; 19(1):51-4. PubMed ID: 15770974
[TBL] [Abstract][Full Text] [Related]
14. Avoidance of misinterpretation of an FDG positive sacral insufficiency fracture using PET/CT scans in a patient with endometrial cancer: a case report.
Halaç M; Mut SS; Sönmezoglu K; Ylmaz MH; Ozer H; Uslu I
Clin Nucl Med; 2007 Oct; 32(10):779-81. PubMed ID: 17885357
[TBL] [Abstract][Full Text] [Related]
15. [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
Halter G; Buck AK; Schirrmeister H; Wurziger I; Liewald F; Glatting G; Neumaier B; Sunder-Plassmann L; Reske SN; Hetzel M
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1093-9. PubMed ID: 15052207
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax.
Demura Y; Tsuchida T; Ishizaki T; Mizuno S; Totani Y; Ameshima S; Miyamori I; Sasaki M; Yonekura Y
J Nucl Med; 2003 Apr; 44(4):540-8. PubMed ID: 12679397
[TBL] [Abstract][Full Text] [Related]
17. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
[TBL] [Abstract][Full Text] [Related]
18. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
19. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
Shreve PD; Grossman HB; Gross MD; Wahl RL
Radiology; 1996 Jun; 199(3):751-6. PubMed ID: 8638000
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT.
Hoshi M; Takada J; Oebisu N; Hata K; Ieguchi M; Nakamura H
Arch Orthop Trauma Surg; 2012 Nov; 132(11):1561-8. PubMed ID: 22825642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
